LAG3 Antikörper (AA 23-245)
Kurzübersicht für LAG3 Antikörper (AA 23-245) (ABIN7092960)
Target
Alle LAG3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 23-245
-
Verwendungszweck
- Anti-LAG3 antibody(DM160), Rabbit mAb
-
Aufreinigung
- Purified from cell culture supernatant by affinity chromatography
-
Immunogen
- Recombinant human LAG3(Leu23-Leu245) (ABIN6964105) produced by using human HEK293 cells
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- ELISA 1:5000-10000, Flow Cyt 1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Andere Bezeichnung
- LAG3
-
Hintergrund
-
Synonyms:LAG-3, CD223
Description:Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4. [provided by RefSeq, Jul 2008] -
Molekulargewicht
- 57.4KDa
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-